Skip to content

A research on the standardized application and clinical evaluation of 'Qihuang needle therapy' in the treatment of Parkinson's disease

A research on the standardized application and clinical evaluation of 'Qihuang needle therapy' in the treatment of Parkinson's disease

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072690
Enrollment
Unknown
Registered
2023-06-21
Start date
2023-06-12
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

experimental group:Qihuang needle therapy + Basic treatment
experimental group:Ordinary acupuncture + Basic treatment
control group:Sham acupuncture + Basic treatment

Sponsors

The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria of Parkinson's disease (2) 60-80 years old; (3) the course of the disease is more than 1 year; (4) Hoehn-Yahr classification is within 1-4; (5) Those who have received PD medication and taken it at a stable dose for more than 2 months; (6) clear consciousness, stable vital signs, no obvious mental retardation and no obvious hearing impairment; (7) The person who signed the informed consent.

Exclusion criteria

Exclusion criteria: (1) Parkinson's syndrome and Parkinson's superposition syndrome caused by cerebrovascular disease, poisoning and other causes; (2) those with serious diseases, such as severe liver and kidney, hematology, tumor, endocrine diseases or pain; (3) Participating in other drugs and acupuncture clinical trials at the same time; (4) mental patients; (5) Deafness or communication barriers; (6) Those who have a history of alcoholism or drug abuse.

Design outcomes

Primary

MeasureTime frame
UPDRS;

Secondary

MeasureTime frame
PDQ-39;Postural balance;Gait analysis;Elastic muscle strength detection;rs-fMRI;Serum inflammatory factors;

Countries

China

Contacts

Public ContactZhenhu Chen

the First Affiliated Hospital of Guangzhou University of Chinese Medicine

936733729@qq.com+86 137 2806 3180

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026